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Objective The World Maternal Antifibrinolytic (WOMAN) Trial
was the first in the UK to use the option of waiver of informed
consent at the time of an obstetric emergency. This qualitative
study aimed to investigate participants’ views of the acceptability
of the recruitment methods used.
Design Qualitative study using in-depth interviews with women
who did and did not give consent at the time of their recruitment
to the WOMAN Trial.
Setting Highest UK recruitment site for the WOMAN Trial
(129/569). Interviews were conducted in participants’
homes.
Population About 40 of the 129 women who were recruited to the
WOMAN Trial at one UK site were invited to take part, 15
women were interviewed.
Methods Qualitative, interview study.
Main outcome measures Facilitators and barriers to successful
recruitment during obstetric emergencies. Guidance for future
researchers.
Results Findings revealed that what is important is not so much
the consent process used or a signature on a form, but the way in
which consent is obtained. Clinicians who successfully negotiate
consent to research during childbirth emergencies engage in a
‘humane choreography’ of words and actions. This emphasises the
importance of prompt decision-making and treatment, while
respecting the woman’s personal situation and experience.
Conclusions Our findings do not support a single pathway to
consent in the context of an obstetric emergency. Women
understand that consent to research in an emergency is complex.
Clinicians’ skills in considering the clinical, ethical, and emotional
aspects within the context of the clinical emergency can hamper
or promote women’s satisfaction.
Keywords Consent, obstetric emergency, research, women’s views.
Tweetable abstract Study reports on women’s views of consent to
research in an obstetric emergency.
Linked article This article is commented on by D Lanz et al. To
view this mini commentary visit https://doi.org/10.1111/1471-
0528.15340.
Plain Language Summary
Why and how was the study carried out?
We undertook this study to find out what women thought about being included in a research study called the WOMAN Trial at the
time they were being treated for heavy bleeding after giving birth. Some women had been asked if they wanted to be a part of the
research at the time they were bleeding. Others were asked later, after they had recovered. We conducted interviews with 15 women
who had been involved and asked what they thought about the way they had been asked, their preferences and ideas for improvements
in future similar studies
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What were the main findings?
Women understood how difficult it was for their doctors and midwives to ask them about the research study. They were pleased to
have been included in the research and were mostly happy with the way they gave consent. Women’s views were similar whether they
were asked about the research at the time of the bleeding or after they had recovered. The most important thing was that doctors and
midwives carefully thought about the situation the woman found herself in and how this might make her feel, so they could tailor
their approach accordingly.
What are the limitations of the work?
This study only involved women from one hospital. The WOMAN Trial included women from many areas of the UK and other
countries around the world. We do not know how their experiences or views may differ.
What is the implication for professionals?
Careful use of actions and words by birth attendants was the difference between a good or bad experience for the woman and her
family. This is an important skill that could be developed as part of professional training.
Please cite this paper as: Houghton G, Kingdon C, Dower M, Shakur-Still H, Alfirevic Z. What women think about consent to research at the time of an
obstetric emergency: a qualitative study of the views of a cohort of World Maternal Antifibrinolytic Trial participants. BJOG 2018; https://doi.org/10.1111/
1471-0528.15333.
Introduction
Debate about consent to research during the vulnerable
time of childbirth and childbirth emergencies is long-
standing.1–5 Guidelines for the conduct of maternity
research where time is critical recognise how informing all
women about potential emergencies in advance may create
unnecessary anxiety.4 However, giving information and
gaining consent at the time can delay potentially lifesaving
treatments.5 The ideal of valid, informed consent becomes
unworkable in some obstetric emergencies, and the devel-
opments of flexible research protocols that acknowledge
this are welcomed. Understanding the views and experi-
ences of those directly involved is paramount. Deferred
consent precedents have been set and evaluated in the con-
text of emergency medicine6–8 and paediatric trials.9,10
However, in obstetrics, deferred consent had only been
explored hypothetically.11 The use of a verbal consent
within emergency peripartum trials is associated with pro-
fessional anxiety.12 The completion of the World Maternal
Antifibrinolytic (WOMAN) Trial presented a unique
opportunity to investigate the views of women who had
lived through this experience.
The WOMAN Trial showed that tranexamic acid, com-
pared to placebo, reduced the risk of death from postpar-
tum haemorrhage (PPH) by 20%.13 The trial faced an
important challenge in terms of consent, as the treatment
being studied needed to be given at the time women were
experiencing a PPH. The trial design included a range of
consent approaches, depending on the woman’s condition
(Figure 1). Consent was obtained from women if their
physical and mental capacity allowed (as judged by the
treating clinician). If a woman was unable to give consent,
proxy consent was obtained from a relative or representa-
tive. If a proxy was unavailable or unable to consent, con-
sent was deferred and the woman was informed about the
trial as soon as possible, written consent was requested later
for data collection. Trial procedures were compliant with
international guidelines and legislative frameworks relating
to consent to emergency research.13–18 The UK Clinical
Trials Regulations Amendment 219 and the updated Decla-
ration of Helsinki.20 In the UK, 569 women were ran-
domised at seven maternity facilities. Five hundred and six
of the 569 women were randomised without prior written
consent, and 501 women gave retrospective written consent
to continue.
This study aimed to investigate the views of a cohort of
the participants in the WOMAN Trial to identify preferred
method(s) of consent, assess the acceptability of waiver of
prior consent and inform future guidance.
Methods
The study is reported following the consolidated criteria
for reporting qualitative research (COREQ) guidelines.21
An interpretative qualitative methodology using in-depth
interviews was used to investigate women’s views.
Participants were recruited from the UK site where the
highest number of WOMAN Trial participants were
recruited (n = 129 of 569). Purposive sampling ensured
maximum variation of interviewees based on the method
of consent used22 (Figure 2). Forty potential participants
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were identified from the randomisation log. Sixteen gave
consent while their PPH was ongoing. Two had prior con-
sent waived and subsequently declined to give written
consent. There were 111 women who had consent waived
and gave consent subsequently. Every fifth woman was
invited, this ensured representation across the Trial’s
Figure 1. Flow chart: guidance for obtaining informed consent for the WOMAN trial.
Recruited to WOMAN Trial and eligible for participation n = 129
Consent waiver n = 113Consent at time n = 16
Interviewed 
n = 6
Approached n = 16
Interviewed 
n = 8
Agreed but not 
arranged n = 1
Deferred consent n = 111 Declined written consent n = 2
Approached n = 2 Approached n = 22 No contact
n = 6
Declined n = 1
*No contact n = 13 Agreed but not 
arranged n = 3
Agreed but 
not 
arranged 
n = 1
Interviewed 
n = 1
Figure 2. Study algorithm and sample characteristics. *It is noteworthy that more women in the waiver group were not contactable. Some women
initially seemed keen to be included; however, interviews were not arranged for a range of reasons: no further telephone contact made, moved out
of area, work/childcare commitments.
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duration (n = 22). Written consent by relatives at the time
of the emergency was not obtained for any of the partici-
pants. Trial recruitment occurred at the site between Octo-
ber 2011 and July 2013. This study was conducted once
recruitment to the WOMAN Trial in the UK was com-
pleted and international recruitment remained ongoing.
Interviews commenced following ethical approval in March
2015, with the intention that the findings would be avail-
able soon after the results of the WOMAN Trial became
available.
Women were sent an Invitation and Information Sheet
and then contacted by telephone. There were opportuni-
ties to ask questions before written consent. Interviews
were audio-recorded and conducted using an interview
schedule (Appendix S1). All participants preferred to be
interviewed at home. Family members and children were
present during some interviews. Data saturation was
reached after 15 interviews; evidenced during the final
interviews and confirmed during initial coding. Partici-
pants consented to information collection from their
records (Table 1).
Interviews were transcribed verbatim to create transcripts
for thematic network analysis.23 This method has parallels
with the basic components of grounded theory, which
organises data into concepts, categories, and propositions.
GH and CK undertook the analysis. In stage one, following
data familiarisation, a coding framework was devised, first
independently, and then agreed by consensus. MAXQDA11
was used to dissect the text into coded segments. Four a pri-
ori codes were assigned, and 19 were grounded in the data
(Appendix S2). GH and CK then abstracted and refined
themes from coded segments, arranging them into nine
basic themes and three organising themes, from which the
global theme was deduced. The initial thematic network was
verified and refined by constant comparative reflection and
discussion. In stage two, GH and CK described and explored
the thematic networks further, before summarising them. In
stage three, GH and CK brought the network summaries
together with existing theories, original research questions,
and the interests underpinning them. Figure 3 was pro-
duced in this final stage.
GH and MD are practicing midwives. CK is a sociologist
and maternity researcher. ZA is an obstetrician and
researcher. GH, MD, and ZA were collaborators in the
WOMAN Trial. HS was lead investigator in the WOMAN
Trial. The ethical dilemmas raised by the unprecedented use
of the waiver of prior consent provided the impetus for this
study. Although there was nothing to suggest that women
were concerned about the consent processes used in the
Trial in terms of complaints and declining continuation,
the research team were reluctant to assume this equated to
unanimous acceptance. GH, CK, and MD conducted the
interviews. As GH and MD were responsible for
recruitment to the WOMAN trial, the trial logs were
checked to ensure that GH and MD did not approach or
interview women they had met in Trial activities.
Results
Fifteen women participated; eight gave consent to partici-
pate in the WOMAN trial while their PPH was ongoing;
for seven, consent was waived (including one of two
women who declined written consent retrospectively). The
study algorithm and sample characteristics are illustrated in
Figure 2. Table 1 reports demographic and clinical charac-
teristics. Figure 3 outlines the thematic structure of the
findings. Interviews lasted 20 minutes to 1½ hours. All
transcripts conveyed the global theme ‘humane choreogra-
phy of clinical, emotional, and ethical considerations when
negotiating consent to research’, underpinned by the three
organising themes (1) Too much to process, (2) Quality of
relationships, and (3) Making it right. Figure 3 illustrates
the interconnectivity between themes.
Theme 1 Women’s experiences: too much to
process
Thirteen of the fifteen women experienced labour; two had
an elective caesarean section; fourteen gave birth to a live
baby. Women explained how their ability to process infor-
mation and make decisions was compromised by having just
given birth and experienced a potentially life-threatening
event. A series of undistinguishable interactions with profes-
sionals were described. All women who signed a consent
form around the time of Trial entry recalled being spoken to
by professionals who were concerned about bleeding. How-
ever, none could remember clearly which conversations
related to clinical care and which were about research: ‘I
think he [the Doctor] explained that it was a trial to do with
stemming blood loss, but that was all a bit hazy. I was sob-
bing. I actually remember saying am I going to die? I didn’t
really know at the time what I was saying yes to’ (C13).
As expected, the consent waiver was used most commonly
when a woman’s consciousness was affected. This meant
some women remembered very little. Six participants signed
consent for continued participation in the hours or days after
recruitment. Few recalled these discussions or signing the
form. Some recalled more when prompted.
Can you remember talking to anybody about taking part
in any research?
No.
Not at all?
I can’t remember that at all.
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Women’s views of consent to research during PPH
The interviewer then showed the ‘Alert Card’ given to all
WOMAN Trial participants
So this is the research that you took part in?
Oh. Right, OK. I have got one of these.
Long pause.
So I have been involved in it then haven’t I?
(W13)
Although we expected the consent waiver to be used
when a woman’s consciousness was impaired, we did not
anticipate how similar the interviews with women recruited
using the three methods would be. Six women lost con-
sciousness, many more described an altered state of con-
sciousness where they were unable to think or remember
clearly.
Views on providing information and obtaining informed
written consent to research at the time of an emergency
varied from hypothetically desirable to an inappropriate
inconvenience. All women understood the need for prompt
action and how delays could compromise any possible ben-
efit the research may offer. One who gave prior consent
said ‘They could have given me a piece of paper to say I
was signing my mortgage away. The signing thing, it’s just
it seems quite pointless really’ (C08). A woman, for whom
the consent waiver was used, said ‘You couldn’t discuss
something like that at that point. It had to be done by
someone else’ (W02). Another from the waiver group
stressed the immediacy of the intervention: ‘I think you
should go ahead if you think it is going to help’ (W16). All
but one participant recruited using the consent waiver felt
that the process was acceptable. Her consciousness appears
to have been affected very briefly, and she felt there were
missed opportunities for discussion.
Among women who provided written consent, some
were initially shocked to learn others had been entered into
the Trial without; ‘I don’t think I would have been happy’
(C04). Others disagreed; ‘I think when you are in a critical
situation, conscious or not, I’d have been happy for them
to waiver consent’ (C09). The woman who declined to sign
a consent form retrospectively was not negative ‘It needs to
be done there and then. Just to go straight to it, in case
any more damage happens’ (D02). Her reason for not sign-
ing was related to early hospital discharge.
Women’s ability to process information was affected at
the time of trial entry and in the days and weeks after-
wards. Women were asked if they looked at Trial informa-
tion later: ‘Not really, you get given all these things, the
pack, little red book and you have got this baby in your
arms. When I get five minutes to myself I will read the
leaflets’ (W16). Overall, women appeared to have little
capacity for research activities in their life-changed, post-
birth, post-PPH, world; for most, the invitation to
Humane choreography of 
clinical, emotional, and 
ethical considerations when 
negotiating consent to 
research in emergency 
settings
Contextualising decision-making as 
determined by gravity of emergency 
situation and significance of events 
immediately before and afterwards
Quality of relationships: Trust, 
communication, interaction and 
respectfulness
Making it right: Human rights, 
realisation, resolution and 
recommendations
Lives in transition amidst 
significant life event(s)
Emotional, sensory, and 
physical overload
No space for informed             
decision-making
Degree of trust, confidence and 
respect in health professionals
Faith in research intervention: Believe 
done to them in good faith and 
whatever they had it worked for them
Belief partners should be included in the 
discussion but degree of involvement in 
actual decision depends on relationship
Women are not willing to give up their 
basic human rights when unconscious 
or unable to remember
Reconciling what happened to them with 
what might be better for others in the 
future It’s more the doing it in the right way, rather 
than what is actually done, that can make it 
right or wrong
Figure 3. Thematic network illustrating basic, organising, and global themes.
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participate in this study was the first time they had found
time to give the WOMAN Trial a thought.
Tables S1–S3 provide more quotes to support the three
organising themes.
Theme 2 Women’s views: quality of relationships
With one exception, interviewees demonstrated immense
trust in professional expertise. The degree of trust reflected
participant’s perceptions of the quality of the relationships
that developed within clinical scenarios. Many recalled
interactions where trust and respect were built or lost. ‘I
remember these two (doctors) being really excited about
the trial. I remember a senior doctor telling them off. I
mostly felt at that time that (wife) was a bit of a guinea
pig’ (Partner of C08).
Participants understood the challenges associated with
conducting research during emergencies and were happy
for the obstetrician to carry this burden. Participants
appeared to understand that a placebo was used, interest-
ingly many firmly believed their clinical situation had been
improved by the Trial medication. ‘In my eyes it worked.
Whether it was water, medication, orange juice, whatever’
(W01).
The woman who was not satisfied felt that her doctor
failed to acknowledge her previous experiences of mother-
hood; ‘The placenta got stuck. I said to her (Doctor) it’s
stuck and she said no it’s not. I said it is. This is number 3
not number 1’ (W22). Women’s views on whether their
birth partner should be involved in decision-making varied,
some recognised how this might be compromised by their
own birth experience ‘I think they would be in a state at
the time’ (C05). Partner’s involvement was viewed as a
courtesy rather than a necessity.
Theme 3 Women’s needs: making it right
While most participants were ‘fine’ with the recruitment
process, many suggested improvements. During the
WOMAN Trial, a brief information leaflet was provided in
clinics. Increasing opportunities for giving information was
important; obtaining a signature on a form was not.
Women articulated the difficulties clinicians face in provid-
ing balanced information during pregnancy and labour ‘I
suppose do you wanna scare people by telling them all the
things that could go wrong?’ (C08). Most women felt an
individualised approach was best, and the complexity of
doing this well was acknowledged ‘I don’t know whether
there is a right way. You’ve just got to do what you can in
the situation at that time’ (W02).
Providing explanations and answering questions at an
appropriate time were crucial. Professional awareness of the
impact that childbirth, particularly a traumatic experience,
can have upon cognitive ability was critical. ‘They could’ve
come the day after when I was more alert, more aware,
and I didn’t have 20 people coming in and out’ (W02).
C04 initially appeared against the idea of retrospective con-
sent; however on reflection, she describes how the explana-
tion was all important. ‘Because it was explained properly,
you go, well I accept that and thanks for taking the time to
go into it and you know sort of do the right thing.’
Many women expressed a positive view of research and
verbalised altruism towards other women and society ‘I
think it’s a very good idea because how else are we meant
to learn for other people for the future’ (W01).
Not missing opportunities for research was also important:
It doesn’t mean that should you come across a lady in
my situation at the time the emergency is going on that
you can’t ask her. (C04)
The global theme humane choreography of consent to
research (‘how it’s done’) encapsulates what really mattered.
How consent was negotiated was judged by perceptions of
respect and the quality of human interactions during care.
Women expected every reasonable effort to be made to
communicate with them; they appreciated why this was not
always easy or achievable. From what first appeared as
indistinguishable fragmented memories of giving birth,
receiving treatment for PPH, and being approached regard-
ing research, emerged the proposition that doing consent
well involves a skilful balance and co-ordination of impor-
tant aspects amidst a plethora of human emotions. This
evoked the metaphor of a complex dance, dynamic and
humanely choreographed when done well; chaotic and dis-
respectful when not.
Discussion
Main findings
Participants favoured no particular WOMAN Trial consent
procedure; instead, they valued a humane choreography of
informed consent appropriate to their personal situation.
This does not run contrary to the principles in the Declara-
tion of Helsinki or more recent policy statements that
highlight the importance of high-quality respectful, human-
ised care.20,24,25 Women completely understood the com-
plexity of issues at play and the associated challenges linked
to consent. Participants were less concerned with proce-
dures and paperwork, and more concerned with the quality
of human interactions. This was indicative of feeling that
professionals had done the right thing at a time when a
decision could not be made fully by the woman herself.
The WOMAN Trial research protocol acknowledged how
the differing clinical scenarios of PPH and the clinical sta-
tus of a woman would determine the consent procedure
used. It was an unanticipated finding of this study just how
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similar participants’ experiences would be, irrespective of
the severity of their PPH or the consent procedure used.
Strengths and limitations
This is the first study of the views of women who have
experienced being included in a randomised controlled trial
of treatment for an obstetric emergency trial where a waiver
of consent was used. A key strength of this study is that it
included women who gave their written consent before
entry into the Trial and women where prior consent was
waived. Opportunities to purposively sample women who
declined were limited. Only women who took part in the
WOMAN trial from one UK site were included in this
study, including women from other sites may have resulted
in more varied responses. As many of the women inter-
viewed for this study did not remember the WOMAN Trial,
there was a need to explain what had actually happened.
Views expressed at interview may therefore have been influ-
enced by the short time participants had to consider their
feelings and thoughts. The interviews took place 1 year or
more after participants were included in the WOMAN trial.
Although existing research suggests that in the long term
(1 year or more), women usually describe aspects of their
labours and birth consistently,26 the effect of this time lapse
on participants in this particular study is unknown.
Interpretation
Conducting emergency obstetric care trials to improve out-
comes for women and negotiating consent to research in
this emergency situation is a necessary component of medi-
cal care. Clinical trials are governed by European Legisla-
tion, which sets the framework for valid informed consent
as the cornerstone of experimental research involving
humans.18 The European Directives made no provision for
consent in critical emergency situations. In 2008, UK legis-
lation was introduced to enable researchers to seek consent
after a person had been given an investigational drug or
device when the following conditions are met: ‘(1) treat-
ment is required urgently; (2) urgent action is required for
the purposes of the trial; (3) it is not reasonably practicable
to obtain consent prospectively; and (4) an ethics commit-
tee has given approval to the procedure under which the
action is taken.’7 However, some clinicians remain very
uncomfortable deferring written consent.12
All women in this study could not recall details of their
involvement in the WOMAN Trial. Most were largely una-
ware that they had been part of a research study, until
approached to participate in this study. This is similar to the
experiences of parents whose children were entered into
emergency research27 and existing studies of women’s experi-
ences of PPH.28 This loss of memory may, in part, reflect the
response of the brain to perceived trauma.29 This recurrent
finding does, however, raise an important question about the
meaningfulness of informed consent in any spheres of clinical
practice where psychological trauma may occur. Akkad
et al.30 proposed that truly informed consent may be impos-
sible to achieve within the context of clinical emergencies.
Some of the women included in this study agree, viewing dis-
cussing consent at such a time as ‘pointless’. Snowdon et al.11
asked women to consider hypothetically what they would do
in this situation. Interviewees rejected decision-making before
delivery, and by their partners/representative at the time of
the emergency. Preferred options were antenatal decisions,
followed by doctors making decisions at the time of the
emergency. The views of women considering the hypothetical
situation were, to an extent, supported in this study.
The principles of informed consent were of utmost impor-
tance, at the same time, women accepted the complexity of
when, how, and by whom this is achievable. Vernon et al.1
previously described a pathway for consent that acknowl-
edged the importance of considering women’s individual sit-
uations. These findings go further in explaining why a ‘one
size fits all’ consent process is inadequate. What is important
is not so much the process, but the way in which it is under-
taken. Hinton et al.’s study31 of near-miss maternal morbidi-
ties supports the importance of the ‘little things’ (personal
touches, flexibility, taking time to explain) in helping women
make sense of complex situations and improving perceptions
of care.
The conduct of the WOMAN Trial did not result in com-
plaints; the absence of complaint is, however, a poor measure
of acceptability. These findings offer detailed insight that can
be used by researchers planning similar studies. Multiple
pathways to consent, when used appropriately within a range
of clinical scenarios, rather than waiver of consent waiver per
se, appear to be acceptable. The women in this study clearly
articulated why complacency is unacceptable and that efforts
to improve consent processes should focus on the quality of
human interactions, increasing opportunities to communi-
cate courtesy and impart information.
Conclusion
The consent procedure in the WOMAN Trial used a
variety of approaches dependent on the clinical scenario.
Overall, all the consent procedures were acceptable, with
no difference in the views of women who gave consent
and those where consent was deferred. The current study
has shown that professional concerns appear largely
unfounded; interviews illustrated that women remember
very little of the emergency or the research. Women
understood that obtaining consent to research in an
emergency is complex and they appreciated an approach
that took their own personal situation into consideration.
Care must be taken not to interpret this as consent is
unimportant. Clinicians need to recognise the importance
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of a humane choreography of clinical, ethical, and emo-
tional considerations and should focus on developing
skills in respectfully obtaining consent in partnership
with women and their families. Professionals could
develop skills by practising research recruitment alongside
scenario-based emergency drills. It is essential that those
responsible for designing future research trials acknowl-
edge the views of these women.
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